Clinical implications for four drugs of the DSM-IV distinction between substance dependence with and without a physiological component.
- Authors
- Schuckit, M A; Daeppen, J B; Danko, G P; Tripp, M L; Smith, T L; Li, T K; Hesselbrock, V M; Bucholz, K K
- Year
- 1999
- Journal
- The American journal of psychiatry
- PMID
- 9892296
- DOI
- 10.1176/ajp.156.1.41
OBJECTIVE: The DSM-IV work group asked researchers and clinicians to subtype substance dependent individuals according to the presence or absence of physiological symptoms. A recent report from the Collaborative Study on the Genetics of Alcoholism demonstrated that among alcohol-dependent men and women, a history of tolerance or withdrawal was associated with a more severe clinical course, especially for individuals with histories of alcohol withdrawal. This article evaluates similar distinctions among subjects in the collaborative study who were dependent on marijuana, cocaine, amphetamines, or opiates. METHOD: Structured interviews gathered information from 1,457 individuals with a lifetime diagnosis of marijuana dependence, 1,262 with histories of cocaine dependence, 647 with amphetamine dependence, and 368 subjects with opiate dependence. For each drug, the clinical course was compared for subjects whose dependence included a history of withdrawal (group 1), those dependent on each drug who denied withdrawal but reported tolerance (group 2), and those who denied both tolerance and withdrawal (group 3). RESULTS: The proportion of dependent individuals who denied tolerance or withdrawal (group 3) ranged from 30% for marijuana to 4% for opiates. For each substance, individuals in groups 1 and 2 evidenced more severe substance-related problems and at least a trend for greater intensities of exposure to the drug; those reporting withdrawal (group 1) showed the greatest intensity of problems. CONCLUSIONS: The designation of dependence in the context of tolerance or withdrawal identifies individuals with more severe clinical histories. These results support the importance of the designation of a physiological component to dependence, especially for people who have experienced a withdrawal syndrome.
No figures extracted from this document.
No chunks — full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Study protocol for a randomised controlled trial to determine the efficacy of lisdexamfetamine for the treatment of acute methamphetamine withdrawal in inpatient settings. | Acheson LS et al. | — | 2025 | → |
| The collaborative study on the genetics of alcoholism: Sample and clinical data. | Dick DM et al. | — | 2023 | → |
| Cocaine Use Disorder (CUD): Current Clinical Perspectives. | Schwartz EKC et al. | — | 2022 | → |
| Utility of a controlled amphetamine withdrawal paradigm among adults who use methamphetamine: A pilot clinical trial. | Thompson RG et al. | — | 2021 | → |
| History of withdrawal modulates drug- and food-cue reactivity in cocaine dependent participants. | Denomme WJ et al. | — | 2020 | → |
| Prevalence of Cannabis Withdrawal Symptoms Among People With Regular or Dependent Use of Cannabinoids: A Systematic Review and Meta-analysis. | Bahji A et al. | — | 2020 | → |
| Commonalities and Differences Across Substance Use Disorders: Phenomenological and Epidemiological Aspects. | Shmulewitz D et al. | — | 2015 | → |
| Central CRF2 receptor antagonism reduces anxiety states during amphetamine withdrawal. | Reinbold ED et al. | — | 2014 | → |
| Psychometric properties of the Spanish version of the Cocaine Selective Severity Assessment to evaluate cocaine withdrawal in treatment-seeking individuals. | Pérez de los Cobos J et al. | — | 2014 | → |
| Serotonin in the ventral hippocampus modulates anxiety-like behavior during amphetamine withdrawal. | Tu W et al. | — | 2014 | → |
| DSM-5 criteria for substance use disorders: recommendations and rationale. | Hasin DS et al. | — | 2013 | → |
| Are the symptoms of cannabis use disorder best accounted for by dimensional, categorical, or factor mixture models? A comparison of male and female young adults. | Gillespie NA et al. | — | 2012 | → |
| Diagnostic criteria for cannabis withdrawal syndrome. | Gorelick DA et al. | — | 2012 | → |
| Treatment of cocaine withdrawal anxiety with guanfacine: relationships to cocaine intake and reinstatement of cocaine seeking in rats. | Buffalari DM et al. | — | 2012 | → |
| Basic subsistence needs and overall health among human immunodeficiency virus-infected homeless and unstably housed women. | Riley ED et al. | — | 2011 | → |
| Alcoholics Anonymous-Related Helping and the Helper Therapy Principle. | Pagano ME et al. | — | 2010 | → |
| Cannabis withdrawal symptoms in non-treatment-seeking adult cannabis smokers. | Levin KH et al. | — | 2010 | → |
| Linkage analyses of cannabis dependence, craving, and withdrawal in the San Francisco family study. | Ehlers CL et al. | — | 2010 | → |
| An item response theory modeling of alcohol and marijuana dependences: a National Drug Abuse Treatment Clinical Trials Network study. | Wu LT et al. | — | 2009 | → |
| Heterogeneity of stimulant dependence: a national drug abuse treatment clinical trials network study. | Wu LT et al. | — | 2009 | → |
| Norepinephrine and stimulant addiction. | Sofuoglu M et al. | — | 2009 | → |
| The construct and measurement equivalence of cocaine and opioid dependences: a National Drug Abuse Treatment Clinical Trials Network (CTN) study. | Wu LT et al. | — | 2009 | → |
| The neuropsychology of cocaine addiction: recent cocaine use masks impairment. | Woicik PA et al. | — | 2009 | → |
| Treatment for amphetamine withdrawal. | Shoptaw SJ et al. | — | 2009 | → |
| Cannabis withdrawal in the United States: results from NESARC. | Hasin DS et al. | — | 2008 | → |
| Cannabis withdrawal predicts severity of cannabis involvement at 1-year follow-up among treated adolescents. | Chung T et al. | — | 2008 | → |
| Clinical implications of tolerance to alcohol in nondependent young drinkers. | Schuckit MA et al. | — | 2008 | → |
| Diagnosing co-morbid drug use in patients with alcohol use disorders. | Arnaout B et al. | — | 2008 | → |
| How should we revise diagnostic criteria for substance use disorders in the DSM-V? | Martin CS et al. | — | 2008 | → |
| Psychometric evaluation of the Amphetamine Cessation Symptom Assessment. | McGregor C et al. | — | 2008 | → |
| Negative consequences associated with dependence in daily cannabis users. | Looby A et al. | — | 2007 | → |
| Reliability of DSM-IV diagnostic criteria using the semi-structured assessment for drug dependence and alcoholism (SSADDA). | Pierucci-Lagha A et al. | — | 2007 | → |
| Treatment outcome predictors for cocaine dependence. | Poling J et al. | — | 2007 | → |
| Severity of drug use, initiation of prenatal care, and maternal-fetal attachment in pregnant marijuana and cocaine/heroin users. | Shieh C et al. | — | 2006 | → |
| Prevalence and correlates of cocaine physical dependence subtypes using the DSM-IV in outpatients receiving opioid agonist medication. | Disney ER et al. | — | 2005 | → |
| The effect of individual cocaine withdrawal symptoms on outcomes in cocaine users. | Sofuoglu M et al. | — | 2005 | → |
| The nature, time course and severity of methamphetamine withdrawal. | McGregor C et al. | — | 2005 | → |
| Limitations in the assessment of DSM-IV cannabis tolerance as an indicator of dependence in adolescents. | Chung T et al. | — | 2004 | → |
| Review of the validity and significance of cannabis withdrawal syndrome. | Budney AJ et al. | — | 2004 | → |
| A 5-year prospective evaluation of DSM-IV alcohol dependence with and without a physiological component. | Schuckit MA et al. | — | 2003 | → |
| A marijuana screening inventory (experimental version): description and preliminary psychometric properties. | Alexander D | — | 2003 | → |
| Association of cocaine withdrawal symptoms with more severe dependence and enhanced subjective response to cocaine. | Sofuoglu M et al. | — | 2003 | → |
| On beyond urine: clinically useful assessment instruments in the treatment of drug dependence. | Carroll KM et al. | — | 2002 | → |
| Predictive factors of persisting illicit drug use in hospitalized heroin addicts. | Grassi MC et al. | — | 2002 | → |
| Prevalence of DSM-IV alcohol diagnoses and symptoms in adolescent community and clinical samples. | Chung T et al. | — | 2002 | → |
| The five-year predictive validity of each of the seven DSM-IV items for alcohol dependence among alcoholics. | Schuckit MA et al. | — | 2002 | → |
| Cocaine withdrawal symptoms and initial urine toxicology results predict treatment attrition in outpatient cocaine dependence treatment. | Kampman KM et al. | — | 2001 | → |
| Do adolescent symptomatology and family environment vary over time with fluctuations in paternal alcohol impairment? | DeLucia C et al. | — | 2001 | → |
| Early clinical manifestations of cannabis dependence in a community sample. | Rosenberg MF et al. | — | 2001 | → |
| Five-year clinical course associated with DSM-IV alcohol abuse or dependence in a large group of men and women. | Schuckit MA et al. | — | 2001 | → |
| Adult psychopathology: issues and controversies. | Widiger TA et al. | — | 2000 | → |
| Amantadine in the treatment of cocaine-dependent patients with severe withdrawal symptoms. | Kampman KM et al. | — | 2000 | → |
| The 5-year clinical course of high-functioning men with DSM-IV alcohol abuse or dependence. | Schuckit MA et al. | — | 2000 | → |
| Toward the DSM-V: the Withdrawal-Gate Model versus the DSM-IV in the diagnosis of alcohol abuse and dependence. | Langenbucher J et al. | — | 2000 | → |
| Clinical characteristics of alcoholism in alcohol-dependent subjects with and without a history of alcohol treatment. | Raimo EB et al. | — | 1999 | → |